| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely cromoglicate sodium 40 milligram/1 milliliter conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Adalimunab 40mg/mL injection solution 1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| cromolynnatriumopløsning a 100 mg/5 ml peroralt koncentrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| natriumcromglycat + isoprenalinsulfat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| natriumcromoglycat + albuterol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| natriumcromoglycat 2 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing pizotifen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| natriumcromglycat til oral anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| inhaleret natriumcromglycat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| natriumcromglycat til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Ergot alkaloid-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| ergotamin + caffein |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| duloxetin 20 mg kapsel med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| duloxetin 40 mg kapsel med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| etanercept 25 mg pulver og solvent til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| aromatisk analgetikum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing cromoglicic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing ergotamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| cromolynnatrium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| tørret lever-præparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Analgetikum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing isometheptene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| injicerbart leverpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| ergotamintartrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing liver extract (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely duloxetine (as duloxetine hydrochloride) 60 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Duloxetine (as duloxetine hydrochloride) 30 mg gastro-resistant oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Aromatic analgesic poisoning NEC |
Causative agent |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Aromatic analgesic poisoning NOS |
Causative agent |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| [X]Poisoning by other analgesics, not elsewhere classified |
Causative agent |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Analgesic poisoning, NEC |
Causative agent |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Sodium cromoglycate [gastro-intestinal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Sodium cromoglycate [asthma] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Sodium cromoglycate compounds |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Hepacon liver extract D 0.1mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing pizotifen in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| oralt ergotamintartrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Isometheptene-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Topical anti-inflammatory prep[1] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Topical anti-inflammatory prep[2] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Other preps for inflamed joints |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Sodium cromoglycate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Antiinflammatoriske præparater |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Sodium cromoglycate [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing duloxetine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| adalimumab 40 mg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,8 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Ergotamine tartrate 2 mg sublingual tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| cromolynnatriumopløsning a 20 mg/2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| leverderivatkompleks 25,5 mg/ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| cromolynnatriuminhalator a 0,8 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| cromolynnatriumopløsning 20 mg ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| cromolynnatriumgas a 100 mg/5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| cromolynnatriumsprayopløsning 5,2 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| cromolynnatriumopløsning a 10 mg/ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| cromolynnatriuminhalator a 800 µg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| cromolynnatriumsprayopløsning a 40 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| cromolynnatriumspray a 8,1 g |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| cromolynnatriumopløsning a 40 mg/ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| cromolynnatriumspray a 0,8 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely cromoglicate sodium 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| oftalmisk cromolynnatrium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| belladonna-alkaloider 0,2 mg + ergotamintartrat 0,6 mg + phenobarbital 40 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| etanercept 50 mg pulver og solvent til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| migrænemiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing caffeine and ergotamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| isometheptenmucat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing adalimumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| belladonna-alkaloider + ergotamintartrat + phenobarbital |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| natriumcromoglycat + xylometazolinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing tumor necrosis factor alpha inhibitor (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| migrænemiddel |
Is a |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing infliximab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Infliximab 100 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Forgiftning med analgetikum, antipyretikum OG/ELLER antireumatikum |
Causative agent |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| [X]Analgesics, antipyretics and anti-inflammatory drugs causing adverse effects in therapeutic use |
Causative agent |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| [X]Antirheumatics causing adverse effects in therapeutic use |
Causative agent |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| [X]Other analgesics, antipyretics and anti-inflammatory drugs causing adverse effects in therapeutic use |
Causative agent |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| [X]Unspecified analgesics, antipyretics and anti-inflammatory drugs causing adverse effects in therapeutic use |
Causative agent |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Forgiftning med opiat OG/ELLER beslægtet narkotikum |
Causative agent |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Overdose of analgesic drug |
Causative agent |
True |
Analgesic (substance) |
Inferred relationship |
Some |
1 |
| overdosis af kombinationsanalgetikum |
Causative agent |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| overdosis af kombinationsanalgetikum, uvist med hvilken hensigt |
Causative agent |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Forgiftning med analgetikum OG/ELLER antipyretikum |
Causative agent |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| tilsigtet overdosis af kombinationsanalgetikum |
Causative agent |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| bivirkning af analgetika, antipyretika og antireumatika |
Causative agent |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Unspecified opium poisoning |
Causative agent |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Opiate or narcotic poisoning NOS |
Causative agent |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Other non-narcotic analgesic poisoning |
Causative agent |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Non-narcotic analgesic poisoning NOS |
Causative agent |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Other analgesic and antipyretic poisoning |
Causative agent |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Other analgesic or antipyretic poisoning NOS |
Causative agent |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Analgesic, antipyretic or antirheumatic poisoning NOS |
Causative agent |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to other analgesics, anti-pyretics and anti-rheumatics |
Causative agent |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to other analgesics, anti-pyretics and anti-rheumatics NOS |
Causative agent |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to analgesics, anti-pyretics and anti-rheumatics NOS |
Causative agent |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Nitrous oxide and oxygen gas analgesia in labor (procedure) |
Direct substance |
False |
Analgesic (substance) |
Inferred relationship |
Some |
1 |
| inhalationsanalgesi under fødsel |
Direct substance |
False |
Analgesic (substance) |
Inferred relationship |
Some |
1 |
FHIR